Rapid diagnosis of Capnocytophaga canimorsus septic shock in an immunocompetent individual using real-time Nanopore sequencing: a case report.
Capnocytophaga canimorsus
Diagnosis
Droplet digital PCR
Nanopore sequencing
Sepsis
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
24 Jul 2019
24 Jul 2019
Historique:
received:
11
12
2018
accepted:
07
06
2019
entrez:
26
7
2019
pubmed:
26
7
2019
medline:
8
10
2019
Statut:
epublish
Résumé
Rapid diagnosis and appropriate treatment is imperative in bacterial sepsis due increasing risk of mortality with every hour without appropriate antibiotic therapy. Atypical infections with fastidious organisms may take more than 4 days to diagnose leading to calls for improved methods for rapidly diagnosing sepsis. Capnocytophaga canimorsus is a slow-growing, fastidious gram-negative bacillus which is a common commensal within the mouths of dogs, but rarely cause infections in humans. C. canimorsus sepsis risk factors include immunosuppression, alcoholism and elderly age. Here we report on the application of emerging nanopore sequencing methods to rapidly diagnose an atypical case of C. canimorsus septic shock. A 62 year-old female patient was admitted to an intensive care unit with septic shock and multi-organ failure six days after a reported dog bite. Blood cultures were unable to detect a pathogen after 3 days despite observed intracellular bacilli on blood smears. Real-time nanopore sequencing was subsequently employed on whole blood to detect Capnocytophaga canimorsus in 19 h. The patient was not immunocompromised and did not have any other known risk factors. Whole-genome sequencing of clinical sample and of the offending dog's oral swabs showed near-identical C. canimorsus genomes. The patient responded to antibiotic treatment and was discharged from hospital 31 days after admission. Use of real-time nanopore sequencing reduced the time-to-diagnosis of Capnocytophaga canimorsus in this case from 6.25 days to 19 h. Capnocytophaga canimorsus should be considered in cases of suspected sepsis involving cat or dog contact, irrespective of the patient's known risk factors.
Sections du résumé
BACKGROUND
BACKGROUND
Rapid diagnosis and appropriate treatment is imperative in bacterial sepsis due increasing risk of mortality with every hour without appropriate antibiotic therapy. Atypical infections with fastidious organisms may take more than 4 days to diagnose leading to calls for improved methods for rapidly diagnosing sepsis. Capnocytophaga canimorsus is a slow-growing, fastidious gram-negative bacillus which is a common commensal within the mouths of dogs, but rarely cause infections in humans. C. canimorsus sepsis risk factors include immunosuppression, alcoholism and elderly age. Here we report on the application of emerging nanopore sequencing methods to rapidly diagnose an atypical case of C. canimorsus septic shock.
CASE PRESENTATION
METHODS
A 62 year-old female patient was admitted to an intensive care unit with septic shock and multi-organ failure six days after a reported dog bite. Blood cultures were unable to detect a pathogen after 3 days despite observed intracellular bacilli on blood smears. Real-time nanopore sequencing was subsequently employed on whole blood to detect Capnocytophaga canimorsus in 19 h. The patient was not immunocompromised and did not have any other known risk factors. Whole-genome sequencing of clinical sample and of the offending dog's oral swabs showed near-identical C. canimorsus genomes. The patient responded to antibiotic treatment and was discharged from hospital 31 days after admission.
CONCLUSIONS
CONCLUSIONS
Use of real-time nanopore sequencing reduced the time-to-diagnosis of Capnocytophaga canimorsus in this case from 6.25 days to 19 h. Capnocytophaga canimorsus should be considered in cases of suspected sepsis involving cat or dog contact, irrespective of the patient's known risk factors.
Identifiants
pubmed: 31340776
doi: 10.1186/s12879-019-4173-2
pii: 10.1186/s12879-019-4173-2
pmc: PMC6657077
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
660Subventions
Organisme : Advance Queensland
ID : partnerships16-231
Organisme : Advance Queensland
ID : partnerships16-231
Organisme : Advance Queensland
ID : partnerships16-231
Références
Clin Microbiol Rev. 2001 Jan;14(1):177-207
pubmed: 11148009
BMC Res Notes. 2012 Dec 26;5:695
pubmed: 23267527
BMJ Case Rep. 2013 Jan 11;2013:null
pubmed: 23314879
J Infect Chemother. 2015 Mar;21(3):215-7
pubmed: 25445385
Eur J Clin Microbiol Infect Dis. 2015 Jul;34(7):1271-80
pubmed: 25828064
Genome Med. 2015 Sep 29;7:99
pubmed: 26416663
PLoS One. 2016 May 26;11(5):e0156299
pubmed: 27228001
Acta Anaesthesiol Scand. 2016 Nov;60(10):1437-1443
pubmed: 27251795
BMJ Case Rep. 2016 Jun 30;2016:
pubmed: 27364692
J Clin Microbiol. 2017 Jun;55(6):1902-1914
pubmed: 28381610
Expert Rev Anti Infect Ther. 2017 Oct;15(10):925-934
pubmed: 28918656
J Emerg Med. 2018 Jun;54(6):871-875
pubmed: 29523423
Int J Surg Case Rep. 2019;55:230-232
pubmed: 30776586
Clin Infect Dis. 2018 Sep 14;67(7):1139-1141
pubmed: 30986294